Clinical Trials Logo

Filter by:
NCT ID: NCT06392477 Recruiting - Clinical trials for B-cell Non Hodgkin Lymphoma

A Study of DR-0201 in Subjects With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Start date: June 2024
Phase: Phase 1
Study type: Interventional

This is a multicenter, multiple expansion cohort, Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-0201 in adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

NCT ID: NCT06391086 Not yet recruiting - Stroke Clinical Trials

Neuromodulation Effect of Focused Ultrasound for Motor Recovery in Patients With Stroke

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Transcranial focused ultrasound (tFUS) can be used as a non-invasive brain neuromodulation technique. Low-intensity focused ultrasound has been demonstrated to be safe and have neuromodulatory effects on the cerebral cortex in healthy human and animal experiments.This study aims to investigate the effect of tFUS on cortical excitability for motor recovery in patients with stroke.

NCT ID: NCT06389734 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Combining Manual Soft Tissue Release and Exercise Training in COPD: the Effect on LF, EC, and CAF

Start date: March 2, 2023
Phase: N/A
Study type: Interventional

The potential effects of combining manual soft tissue release and physical exercise training on lung function, exercise capacity, and cardiac autonomic function in patients with moderate and severe chronic obstructive pulmonary disease were investigated.

NCT ID: NCT06385080 Recruiting - Clinical trials for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer

OrigAMI-4
Start date: April 22, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, and amivantamab in addition to paclitaxel in participants with recurrent/metastatic head and neck cancer. The study will also confirm the recommended Phase 2 combination dose (RP2CD) for amivantamab in addition to paclitaxel.

NCT ID: NCT06384950 Recruiting - Clinical trials for Carcinoma, Hepatocellular

Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma

Start date: March 22, 2024
Phase: N/A
Study type: Interventional

Liver cancer is a leading cause of cancer-related deaths in Taiwan, with its onset linked to factors like chronic liver conditions, cirrhosis, and genetic predispositions. According to the "Barcelona Clinic Liver Cancer (BCLC)" classification, early-stage liver cancer is demarcated by stages 0 to A. Upon such diagnosis, both patients and their families often have numerous questions and concerns, ranging from treatment choices to long-term outcomes. The research proposes a GPT-3.5-based chatbot to assist these patients by providing timely, personalized information, aiming to enrich their understanding of the disease and improve communication between patients and health professionals. The research methodology employs a Randomized Controlled Trial (RCT) design, dividing participants into a control cohort receiving standard patient education routine and an experimental cohort receiving both the AI chatbot and traditional education routine. The comparative analysis of these cohorts will determine the effectiveness of the AI intervention in improving patients' health literacy and satisfaction.

NCT ID: NCT06383442 Completed - Clinical trials for Overweight or Obesity

HIIT on Overweight Middle-aged Adults

HIIT
Start date: May 25, 2021
Phase: N/A
Study type: Interventional

36 middle-aged with overweight adults were divided into three groups: 1. L-HIIT group: the long-interval HIIT group (4 × 4 min Exercise/4 min Rest), 2. M-HIIT group: the medium-interval HIIT group (8 × 2 min Exercise/2 min Rest), 3. Control group: no exercise intervention. All groups carried out the training stage for 8 weeks (three sessions per week) and the detraining stage for 4 weeks in order to investigate the effects induced by different HIIT interventions on inflammation, metabolic adaptation, anti-fatigue and exercise performance, and fat loss.

NCT ID: NCT06383013 Recruiting - Diabetic Foot Ulcer Clinical Trials

Phase II Study of BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

Start date: February 29, 2024
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic lower leg and foot ulcer.

NCT ID: NCT06382324 Recruiting - Clinical trials for Anterior Cruciate Ligament (Acl) Reconstruction

The Psychological Impact of Mindfulness Intervention to Anterior Cruciate Ligament Reconstruction

Start date: April 23, 2024
Phase: N/A
Study type: Interventional

Anterior cruciate ligament (ACL) reconstruction surgery is a common procedure performed by orthopedic surgeons. Postoperatively, patients often experience pain, muscle tension, and concerns about their ability to return to sports. These factors influence the recovery and return to sports capabilities of ACL patients. According to research, only 64% of patients are able to recover to their pre-injury level after surgery, and the success rate for returning to competitive sports is only 56%. Psychological factors during the recovery process may explain this disparity. ACL injury is associated with anxiety, pain reaction, and emotional disorders, with fear of re-injury being the most common obstacle to returning to sports, accounting for 19%. A study by Lentz et al. (2015) also found no significant differences in pain assessments between individuals who were afraid of re-injury and those who were able to return to sports at six months and one year after surgery. This suggests that fear of pain may limit activity and increase the risk of unsuccessful return to sports. Mindfulness intervention is a psychological approach that involves non-judgmental awareness and focus on moment to moment. Mindfulness practice is known to reduce stress in athletes, promote recovery, enhance athletic performance, and improve sleep quality. Good sleep quality contributes to emotional stability and physical recovery. Even short daytime naps can be beneficial for athletes. A review of 37 studies of moderate quality found that daytime napping can improve physical and cognitive performance, psychological state, and nighttime sleep. Therefore, investigators hypothesize that integrating mindfulness practice into daytime napping may lead to improved spirit upon waking, reduce sleep inertia, and over time, potentially increase the rate of return to sports after ACL reconstruction.

NCT ID: NCT06381986 Not yet recruiting - Corneal Erosion Clinical Trials

Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients

Start date: May 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to measure efficacy and safety with 0.25% SHJ002 sterile ophthalmic solution compared to vehicle in treating corneal erosion in Sjogren's patients. SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.

NCT ID: NCT06381778 Recruiting - Clinical trials for Hypertrophic Cardiomyopathy

Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis

Start date: February 6, 2023
Phase:
Study type: Observational

Hypertrophic cardiomyopathy (HCM) is hallmarked by the presence of left ventricular hypertrophy (LVH) and may present various symptoms including arrhythmia and heart failure. Mutations in the genes related to sarcomeric proteins and metabolic disorders are known causes of HCM. However, it remains required to further explore the prevalence of HCM in the context of Taiwanese' genetic background. Additionally, certain rare diseases that affect the heart, including Fabry disease, cardiac amyloidosis, may present LVH, which makes precise diagnosis among HCM and these diseases more challenging. In this TSOC multi-center registry, we aim to systematically evaluate the clinical, genetic, biochemical features,prevalence, and possible natural course of HCM and relevant rare diseases such as Fabry disease in Taiwan. In the meanwhile, we may also generate the specific "red-flag" signs of Fabry disease in Taiwan.